Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 692 | 1,741 | 2,847 | 1,072 | 2 |
| Marketable Securities | N/A | N/A | N/A | 1,019 | N/A |
| Other current assets | 0 | 22 | 63 | 228 | 54 |
| TOTAL | $1,007 | $2,020 | $2,952 | $2,337 | $104 |
| Non-Current Assets | |||||
| PPE Net | 9 | 17 | 26 | 22 | 0 |
| Intangibles | 9,643 | 10,438 | 0 | 0 | 0 |
| Other Non-Current Assets | 225 | 6 | 6 | 6 | 0 |
| TOTAL | $9,876 | $10,461 | $31 | $28 | $0 |
| Total Assets | $10,883 | $12,481 | $2,983 | $2,365 | $104 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 803 | 230 | 2,449 | N/A | 1,366 |
| Accounts payable and accrued liabilities | 76 | 292 | 51 | 15 | 159 |
| Accrued Expenses | 235 | 124 | 100 | 83 | 137 |
| TOTAL | $1,192 | $646 | $2,600 | $98 | $2,083 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 147 | 0 | 10 | 0 | 0 |
| TOTAL | $1,679 | $2,134 | $10 | $N/A | $N/A |
| Total Liabilities | $2,871 | $2,780 | $2,610 | $98 | $2,083 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 274 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 1 | 4 | 3 | 1 |
| Retained earnings | -10,982 | -7,624 | -3,859 | -2,003 | -14,875 |
| Other shareholders' equity | 0 | -1,800 | 0 | 0 | -1,428 |
| TOTAL | $8,013 | $9,701 | $373 | $2,267 | $-1,979 |
| Total Liabilities And Equity | $10,883 | $12,481 | $2,983 | $2,365 | $104 |